< 生产厂家价格 >

6-甲氧基吲哚

6-甲氧基吲哚用途

有机合成中间体。

点击显示

6-甲氧基吲哚名称

[ CAS 号 ]:
3189-13-7

[ 中文名 ]:
6-甲氧基吲哚

[ 英文名 ]:
6-Methoxyindole

[中文别名 ]:

6-甲氧吲哚

[英文别名 ]:

indole, 6-methoxy-
EINECS 221-689-6
6-methoxy-indole
5-Methoxyindole,~
6-MeO-indole
6-Methoxyindole
Methoxyindole
6-Methoxy-1H-indole
6-methoxylindole
MFCD00022780

6-甲氧基吲哚物理化学性质

[ 密度 ]:
1.2±0.1 g/cm3

[ 沸点 ]:
297.8±13.0 °C at 760 mmHg

[ 熔点 ]:
90-92 °C(lit.)

[ 分子式 ]:
C₉H₉NO

[ 分子量 ]:
147.174

[ 闪点 ]:
109.2±10.1 °C

[ 精确质量 ]:
147.068420

[ PSA ]:
25.02000

[ LogP ]:
2.00

[ 外观性状 ]:
白色结晶粉末

[ 蒸汽压 ]:
0.0±0.6 mmHg at 25°C

[ 折射率 ]:
1.637

[ 储存条件 ]:
Keep Cold

6-甲氧基吲哚MSDS

详细MSDS(安全技术说明书)

6-甲氧基吲哚安全信息

[ 符号 ]:

GHS07

[ 信号词 ]:
Warning

[ 危害声明 ]:
H315-H319-H335

[ 警示性声明 ]:
P261-P305 + P351 + P338

[ 个人防护装备 ]:
dust mask type N95 (US);Eyeshields;Gloves

[ 危害码 (欧洲) ]:
Xi:Irritant

[ 风险声明 (欧洲) ]:
R36/37/38

[ 安全声明 (欧洲) ]:
S26-S36

[ 危险品运输编码 ]:
NONH for all modes of transport

[ WGK德国 ]:
3

[ 海关编码 ]:
2933990090

6-甲氧基吲哚上下游产品

6-甲氧基吲哚上游产品

6-甲氧基吲哚下游产品

6-甲氧基吲哚海关

[ 海关编码 ]: 2933990090

[ 中文概述 ]:
2933990090. 其他仅含氮杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%

[ 申报要素 ]: 品名, 成分含量, 用途, 乌洛托品请注明外观, 6－己内酰胺请注明外观, 签约日期

[ Summary ]:
2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

6-甲氧基吲哚文献

Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators.

J. Med. Chem. 54 , 5320, (2011)

Tryptophan catabolism mediated by indoleamine 2,3-dioxygenase (IDO) is an important mechanism of peripheral immune tolerance contributing to tumoral immune resistance. IDO inhibition is thus an active...

Discovery of a novel class of PPARdelta partial agonists.

Bioorg. Med. Chem. Lett. 18 , 5018, (2008)

Anthranilic acid GW9371 was identified as a novel class of PPARdelta partial agonist through high-throughput screening. The design and synthesis of SAR analogues is described. GSK1115 and GSK7227 show...

Synthesis and evaluation of 3-aroylindoles as anticancer agents: metabolite approach.

J. Med. Chem. 52 , 4941, (2009)

BPR0L075 (2) is a potential anticancer drug candidate designed from Combretastatin A-4 (1) based on the bioisosterism principle. Metabolites of 2, proposed from in vitro human microsome studies, were ...

更多文献